Clinical trial
Study of the Neuronal Substrates of the Cognitive Action Control in Parkinson's Disease Using High Density EEG
NCT03981913 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Neuronal Substrates of the Cognitive Action Control in Parkinson's Disease Using High Density EEG
- Lead sponsor
- Rennes University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 6, 2019
- Completion date
- March 10, 2022
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease